M&As this week: Zhejiang Conba Pharma, CHA Healthcare

23rd February 2017 (Last Updated February 23rd, 2017 18:30)

Conba Group’s subsidiary Zhejiang Conba Pharmaceutical has completed the sale of 57.3% stake in a pharmaceutical company.

Conba Group’s subsidiary Zhejiang Conba Pharmaceutical has completed the sale of 57.3% stake in a pharmaceutical company.

"Zhejiang Conba has received a consideration of ¥345.1m ($50.27m) from the stake sale."

Zhejiang Conba has received a consideration of ¥345.1m ($50.27m) from the stake sale.

Based in China, Zhejiang Conba Pharmaceutical sells medicines and chemical products.

Chabiotech subsidiary CHA Healthcare has reached an agreement to acquire 8.8% stake in Singapore Medical Group.

The stake represents 30 million shares of the target company and costs KRW12.07bn ($10.23m) for the acquirer company.